Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1076.9 (INR) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018
Operating Activities:
Net Income 3,002.8055,597.2986,675.8984,676.7414,045.1181,578.671
Depreciation & Amortization 545.956464.599382.55312.207236.829114.968
Deferred Income Tax 000000
Stock Based Compensation 19.94500000
Change In Working Capital 474.11856.357-1,939.661-112.819452.278-883.266
Accounts Receivables -228.0231,244.652-1,360.88133.608346.183-2,037.386
Inventory 816.149-293.932-823.369-262.082-177.739-170.892
Accounts Payables -281.738-407.259232.035119.452171.28998.536
Other Working Capital 167.73-487.10412.553-103.797112.5451,226.476
Other Non Cash Items -457.993-1,609.13-1,818.785-1,041.752-574.724-306.326
Operating Cash Flow 3,584.8314,509.1243,300.0023,834.3774,159.501504.047
Investing Activities:
Investments In Property Plant And Equipment -517.869-2,857.715-751.867-1,108.46-994.146-567.859
Acquisitions Net 00.720.0060.3361.3430
Purchases Of Investments -3,135.533-0.044-3,002.743-2,005.831-3,251.403-68.977
Sales Maturities Of Investments 11.1844.7812,440.974-0.3363,250.060
Other Investing Activites 19.7763.836-48.4390.309-3,221.109-17.96
Investing Cash Flow -3,622.532-1,948.422-1,362.069-3,113.982-4,215.255-654.796
Financing Activities:
Debt Repayment -63.512-263.68-481.944-424.2480517.839
Common Stock Issued 000000
Common Stock Repurchased 000000
Dividends Paid 0-2,036.52-1,018.26-254.565-767.229-230.169
Other Financing Activities -74.511-119.312-63.917-77.804-0.839-27.892
Financing Cash Flow -138.023-2,358.312-1,564.121-765.52963.677259.778
Other Information:
Effect Of Forex Changes On Cash 0.00900.0040.0030.0060
Net Change In Cash -175.716202.39373.816-45.1317.924109.029
Cash At End Of Period 472.312648.028445.63871.822116.953109.029